The MAPK cascade leads to activation of ERK1 and ERK2 which translocate into the nucleus to regulate MiTF, cMYC and other transcription factors to sustain cell cycle progression, tumor invasion, metastasis and immune evasion [77]. The gene discussed is MITF; the disease is neoplasm.